Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Keith Alan Johnson, M.D.

Co-Author

This page shows the publications co-authored by Keith Johnson and Georges El Fakhri.
Connection Strength

1.795
  1. In vivo and neuropathology data support locus coeruleus integrity as indicator of Alzheimer's disease pathology and cognitive decline. Sci Transl Med. 2021 09 22; 13(612):eabj2511.
    View in: PubMed
    Score: 0.247
  2. The cortical origin and initial spread of medial temporal tauopathy in Alzheimer's disease assessed with positron emission tomography. Sci Transl Med. 2021 01 20; 13(577).
    View in: PubMed
    Score: 0.236
  3. Multi-Modal Signatures of Tau Pathology, Neuronal Fiber Integrity, and Functional Connectivity in Traumatic Brain Injury. J Neurotrauma. 2019 12 01; 36(23):3233-3243.
    View in: PubMed
    Score: 0.213
  4. Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex. JAMA Neurol. 2017 07 01; 74(7):813-820.
    View in: PubMed
    Score: 0.184
  5. Tau and amyloid ß proteins distinctively associate to functional network changes in the aging brain. Alzheimers Dement. 2017 Nov; 13(11):1261-1269.
    View in: PubMed
    Score: 0.181
  6. National Electrical Manufacturers Association and Clinical Evaluation of a Novel Brain PET/CT Scanner. J Nucl Med. 2016 Apr; 57(4):646-52.
    View in: PubMed
    Score: 0.166
  7. Quantitative SPECT leads to improved performance in discrimination tasks related to prodromal Alzheimer's disease. J Nucl Med. 2004 Dec; 45(12):2026-31.
    View in: PubMed
    Score: 0.077
  8. MRI-guided SPECT perfusion measures and volumetric MRI in prodromal Alzheimer disease. Arch Neurol. 2003 Aug; 60(8):1066-72.
    View in: PubMed
    Score: 0.070
  9. Attenuation correction using deep Learning and integrated UTE/multi-echo Dixon sequence: evaluation in amyloid and tau PET imaging. Eur J Nucl Med Mol Imaging. 2021 05; 48(5):1351-1361.
    View in: PubMed
    Score: 0.058
  10. MR-based PET attenuation correction using a combined ultrashort echo time/multi-echo Dixon acquisition. Med Phys. 2020 Jul; 47(7):3064-3077.
    View in: PubMed
    Score: 0.056
  11. Evaluation of pharmacokinetic modeling strategies for in-vivo quantification of tau with the radiotracer [18F]MK6240 in human subjects. Eur J Nucl Med Mol Imaging. 2019 Sep; 46(10):2099-2111.
    View in: PubMed
    Score: 0.053
  12. GRAPH CONVOLUTIONAL NEURAL NETWORKS FOR ALZHEIMER'S DISEASE CLASSIFICATION. Proc IEEE Int Symp Biomed Imaging. 2019 Apr; 2019:414-417.
    View in: PubMed
    Score: 0.053
  13. Visual cognition in non-amnestic Alzheimer's disease: Relations to tau, amyloid, and cortical atrophy. Neuroimage Clin. 2019; 23:101889.
    View in: PubMed
    Score: 0.053
  14. PET Image Deblurring and Super-Resolution with an MR-Based Joint Entropy Prior. IEEE Trans Comput Imaging. 2019 Dec; 5(4):530-539.
    View in: PubMed
    Score: 0.052
  15. Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue. Acta Neuropathol Commun. 2019 03 11; 7(1):37.
    View in: PubMed
    Score: 0.052
  16. Pharmacokinetic Evaluation of the Tau PET Radiotracer 18F-T807 (18F-AV-1451) in Human Subjects. J Nucl Med. 2017 Mar; 58(3):484-491.
    View in: PubMed
    Score: 0.044
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.